Facebook Twitter RSS
  • Search this Website
 
Skip to content
  • About Us
    • Our Vision
    • Intervention Strategies
    • Member – Government Committees
    • Annual Reports
    • Our Trustees
    • Donors
    • FCRA Information
  • Our Work
    • Pandemics and COVID-19
      • Helplines
      • Statements
      • High Court Order
      • Articles
      • Community Voices
      • Relief & Other Support for Covid-19
      • Intersectional Feminist Framework
      • Consultations on Gender, Equity & Covid-19 Vaccines
      • Webinar Series Pandemics & Public Health
      • Webinar Series on Vaccine Research & Access
      • Webinars on Covid-19
      • Videos and Podcasts
    • Public Health & Right to Health
    • Surrogacy & ARTs
      • Conference Participation & Seminars
      • Workshops & Discussions
      • Reports & Studies
      • Consultations
      • Film / Media
      • Policy Level Advocacy
      • Publications
      • Media Resources
    • Gender Based Violence
    • Sexual and Reproductive Health
    • Ethics in Clinical Trials, Access to Medicines
    • Young Women and Mental Health
    • Bioethics
    • Early Marriage and Health
    • Population Policies & Two Child Norm
  • Publications
    • Research Reports
    • Consultation Reports
    • Policy Briefs
    • Capacity Building Tools
    • Fact Finding Reports
    • Articles and Edited Volumes
    • Posters
    • Films & Videos
  • Archives
    • Clinical Trials
      • General
      • Affordability
      • Availability & Accessability
      • Compensation
      • Informed Consent
      • Recuritment
      • Bioethics
      • Guidelines & Legislations
  • Photo Gallery
  • Contact
  • Internship
  • Support Us

Category: Guidelines & Legislations

CDSCO plans more steps to further streamline clinical trial sector

  By admin Archives, Clinical Trials, Guidelines & Legislations

Joseph Alexander | PharmaBiz.com | New Delhi | 10 April 2014 As part of the efforts to further streamline the clinical trials sector with more transparency and accountability, the functioning of the New Drug Advisory Committees (NDACs) will also be… Continue reading

Inadequacies of Clinical Trial Regulations in India

  By admin Archives, Clinical Trials, Guidelines & Legislations

Ashna Ashesh, Zubin Dash | 5 NUJS L. Rev. 379 (2012) Read full article   Continue reading

The EU-India free trade agreement and access to medicines

  By admin Archives, Clinical Trials, Guidelines & Legislations

Third World Network | Third World Resurgence | No. 259, March 2012, pp 15-19 The free trade agreement which India is negotiating with the European Union threatens to jettison some of the health safeguards in India’s patent legislation which make possible… Continue reading

Ethical Guidelines for Biomedical Research on Human Participants

  By admin Archives, Clinical Trials, Guidelines & Legislations

Indian Council of Medical Research, New Delhi | 2006 The release of revised Ethical guidelines for Biomedical Research on Human subjects by the Council in 2000 was followed by a number of developments in science and technology. These have led to further… Continue reading

The Drugs and Cosmetics Act, 1940

  By admin Archives, Clinical Trials, Guidelines & Legislations

Ministry of Health and Family Welfare, Government of India | As amended up to 30 June 2005 This volume also includes The Drugs and Cosmetics Rules 1945, as amended up to 30 June 2005. Read full article   Continue reading

Guidelines for bioavailability and bioequivalence studies

  By admin Archives, Clinical Trials, Guidelines & Legislations

Central Drugs Standard Control Organization, Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, New Delhi | March 2005 Read full article   Continue reading

123
  • Announcements

    • ​’Working hope: How ASHAs mediate between their communities and the health system’
    • Innovative practices to address GBV in the Asia Pacific region in the pandemic context 
    • Webinar: “Relooking local production and R&D: Why the TRIPS waiver is still relevant”
    • Short course: GBV & Health systems roles and accountability
    • Webinar on Intersectionality and Equity in Intellectual Property Rights in Healthcare
  • What’s New

    • Examining the Contested Political and Economic Landscape of Assisted Reproductive Technology and Surrogacy Regulations in India
    • ​’Working hope: How ASHAs mediate between their communities and the health system’
    • The Unravelling Pandemic: Envisioning our Intersectional Feminist Futures
    • Regulation of Surrogacy in India
    • Dignity in death or discrimination in death?
  • Training, Building Capacities and Leadership

    Our Trainings and Capacity Building activities facilitate mobilization and provide support towards organizing around health issues and promoting health rights. They contribute to … Read more »

  • Research

    Research is an integral component of Sama’s work. Research is carried out on issues that the organization is already advocating around or in situations where we feel that there is a need to initiate … Read more »

  • Advocacy

    Sama recognizes the critical role of advocacy in building collective understanding on various issues and to strengthen and sustain campaigns around them. Advocacy initiatives of Sama, including … Read more »

  • Knowledge Creation

    Sama undertakes Creation of Knowledge Resources and their Dissemination on different issues pertaining to women and health. This forms our core strategy on various issues and initiatives that Sama … Read more »

  • About Us
  • Our Work
  • Publications
  • Archives
  • Photo Gallery
  • Contact
  • Internship
  • Support Us
© Sama – Resource Group for Women and Health, 2021
Powered by Parabola & WordPress.
Facebook Twitter RSS